Interestingly, differences in R3HDM1 expression were found across various molecular subtypes of 17 cancers, including LUAD, suggesting its involvement in tumor progression and its potential for precise molecular stratification therapy and predictive value (Supplementary Figure 6). This evidence concerns the gene R3HDM1 and cancer.